KORU Medical Systems, Inc. (KRMD)
3.05
+0.02
(+0.66%)
USD |
NASDAQ |
Nov 06, 10:28
KORU Medical Systems Enterprise Value : 134.85M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 134.85M |
| November 04, 2026 | 145.93M |
| November 03, 2026 | 138.08M |
| November 02, 2026 | 135.78M |
| October 30, 2026 | 133.01M |
| October 29, 2026 | 144.08M |
| October 28, 2026 | 143.62M |
| October 27, 2026 | 141.31M |
| October 26, 2026 | 139.01M |
| October 23, 2026 | 141.31M |
| October 22, 2026 | 136.93M |
| October 21, 2026 | 138.54M |
| October 20, 2026 | 135.31M |
| October 19, 2026 | 134.39M |
| October 16, 2026 | 133.47M |
| October 15, 2026 | 134.85M |
| October 14, 2026 | 138.54M |
| October 13, 2026 | 133.47M |
| October 12, 2026 | 132.08M |
| October 09, 2026 | 131.62M |
| October 08, 2026 | 133.47M |
| October 07, 2026 | 132.54M |
| October 06, 2026 | 133.47M |
| October 05, 2026 | 133.93M |
| October 02, 2026 | 131.62M |
| Date | Value |
|---|---|
| October 01, 2026 | 134.39M |
| September 30, 2026 | 130.24M |
| September 29, 2026 | 133.70M |
| September 28, 2026 | 136.24M |
| September 25, 2026 | 143.16M |
| September 24, 2026 | 145.93M |
| September 23, 2026 | 145.93M |
| September 22, 2026 | 147.77M |
| September 21, 2026 | 144.08M |
| September 18, 2026 | 144.08M |
| September 17, 2026 | 143.62M |
| September 16, 2026 | 142.70M |
| September 15, 2026 | 140.85M |
| September 14, 2026 | 139.93M |
| September 11, 2026 | 140.85M |
| September 10, 2026 | 140.39M |
| September 09, 2026 | 140.39M |
| September 08, 2026 | 141.31M |
| September 04, 2026 | 145.00M |
| September 03, 2026 | 143.62M |
| September 02, 2026 | 147.31M |
| September 01, 2026 | 147.31M |
| August 31, 2026 | 147.31M |
| August 28, 2026 | 144.08M |
| August 27, 2026 | 142.70M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 10.45B |
| Abbott Laboratories | 224.21B |
| AngioDynamics, Inc. | 477.80M |
| Alphatec Holdings, Inc. | 1.734B |
| AtriCure, Inc. | 3.030B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.2524M |
| Revenue (Quarterly) | 12.05M |
| Total Expenses (Quarterly) | 11.79M |
| EPS Diluted (Quarterly) | 0.0051 |
| Gross Profit Margin (Quarterly) | 63.40% |
| Profit Margin (Quarterly) | 2.10% |
| Earnings Yield | -1.30% |
| Normalized Earnings Yield | -1.298 |